MAPT and Alzheimer disease: AD-FTD co-diagnosis, often referred to as “mixed dementia” due to the presence of cognitive and behavior symptomatology, is less frequent [16]; it involves the presence of both tau and amyloid-beta pathology associated with AD, along with TDP-43 or tau pathologies characteristic of FTD.